Busulfan
Back to searchMolecule Structure
Scientific Name
Busulfan
Description of the Drug
Busulfan is an alkylating agent used to treat chronic myelogenous leukemia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01008
http://www.drugbank.ca/drugs/DB01008
Brand Name(s)
Busilvex, Busulfan, Busulfex, Myleran
Company Owner(s)
Nexus Pharmaceuticals Inc, Apotex Inc, Mylan Laboratories Ltd, Otsuka Pharmaceutical Co Ltd, Pharmascience Inc, Hospira Inc, Arthur Group Llc, American Regent Inc, Shilpa Medicare Ltd, Meitheal Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4373 | ||
PharmGKB | PA448691 | ||
Human Metabolome Database | HMDB0015143 | ||
DrugBank | DB01008 | ||
PubChem: Thomson Pharma | 15221088 | ||
PubChem | 2478 | ||
Mcule | MCULE-1840882522 | ||
NMRShiftDB | 20198916 | ||
LINCS | LSM-5388 | ||
Nikkaji | J2.316G | ||
BindingDB | 50237623 | ||
EPA CompTox Dashboard | DTXSID3020910 | ||
DrugCentral | 438 | ||
ChemicalBook | CB2105891 | CB72673681 | |
Guide to Pharmacology | 7136 | ||
rxnorm | BUSULFAN | MYLERAN | BUSULFEX |
KEGG Ligand | C06862 | ||
ChEBI | 28901 | ||
ZINC | ZINC000001530572 |